Epidemiologic study of human influenza virus infection in South Korea from 1999 to 2007: origin and evolution of A/Fujian/411/2002-like strains.
Influenza epidemics arise through the accumulation of viral genetic changes, culminating in a novel antigenic type that is able to escape host immunity. Following an outbreak of the A/Fujian/411/2002-like strains in Asia, including China, Japan, and South Korea, in 2002, Australia and New Zealand experienced substantial outbreaks of the same strains in 2003, and subsequently worldwide outbreaks occurred in the 2003-2004 season. The emergence of A/Fujian/411/2002-like strains coincided with a higher level of influenza-like illness in South Korea than what is seen at the peak of a normal season, and there was at least a year's difference between South Korea and the United States. Genetic evolution of human influenza A/H3N2 viruses was monitored by sequence analysis of hemagglutinin (HA) genes collected in Asia, including 269 (164 new) HA genes isolated in South Korea from 1999 to 2007. The Fujian-like influenza strains were disseminated with rapid sequence variation across the antigenic sites of the HA1 domain, which sharply distinguished between the A/Moscow/10/1999-like and A/Fujian/411/2002-like strains. This fast variation, equivalent to approximately 10 amino acid changes within a year, occurred in Asia and would be the main cause of the disappearance of the reassortants, although the reassortant and nonreassortant Fujian-like strains circulated simultaneously in Asia.
Kang
Seokha
S
Department of Biotechnology & Bioinformatics, College of Science & Technology, Korea University, Chungnam, South Korea.
Yang
In Seok
IS
Lee
Joo-Yeon
JY
Park
Yiho
Y
Oh
Hee-Bok
HB
Kang
Chun
C
Kim
Kyung Hyun
KH
D000956:Antigens, Viral / Q000235:genetics; D016000:Cluster Analysis; D019143:Evolution, Molecular; D014644:Genetic Variation; D006389:Hemagglutinins, Viral / Q000235:genetics; D006801:Humans; D053122:Influenza A Virus, H3N2 Subtype / Q000235:genetics* / Q000302:isolation & purification; D007251:Influenza, Human / Q000453:epidemiology* / Q000821:virology*; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010802:Phylogeny; D017434:Protein Structure, Tertiary; D012367:RNA, Viral / Q000235:genetics; D016865:Reassortant Viruses / Q000235:genetics; D056910:Republic of Korea / Q000453:epidemiology; D017422:Sequence Analysis, DNA; D017386:Sequence Homology, Amino Acid
D000956:Antigens, Viral; D006389:Hemagglutinins, Viral; D012367:RNA, Viral; C458881:hemagglutinin fusogenic peptide, influenza virus
Nature. 2003 Mar 27;422(6930):428-33
12660783
J Med Virol. 2004 May;73(1):71-8
15042651
Virol J. 2008 Mar 07;5:40
18325125
Science. 2004 Jul 16;305(5682):371-6
15218094
Nature. 1981 Jan 29;289(5796):373-8
6162101
Annu Rev Med. 2000;51:407-21
10774473
Chin Med J (Engl). 1997 Aug;110(8):637-41
9594271
J Infect Dis. 2009 Oct 15;200(8):1232-41
19743921
Syst Biol. 2003 Oct;52(5):696-704
14530136
Virology. 2005 May 25;336(1):113-9
15866076
J Clin Microbiol. 2008 Feb;46(2):399-405
17942644
Virology. 1998 Feb 1;241(1):101-11
9454721
Syst Biol. 2006 Aug;55(4):539-52
16785212
J Virol. 2003 Sep;77(18):10088-98
12941919
PLoS Pathog. 2007 Sep 14;3(9):1220-8
17941707
Science. 2008 Apr 18;320(5874):340-6
18420927
J Med Virol. 2005 Jul;76(3):391-7
15902711
Vaccine. 2002 Aug 19;20(25-26):3068-87
12163258
J Clin Microbiol. 2005 Dec;43(12):6130-2
16333111
Science. 1999 Dec 3;286(5446):1921-5
10583948
Mol Biol Evol. 2007 Aug;24(8):1596-9
17488738
PLoS Biol. 2005 Sep;3(9):e300
16026181
PLoS Med. 2006 Apr;3(4):e89
16509764
N Engl J Med. 2009 Jul 16;361(3):279-85
19564632
J Hered. 2000 May-Jun;91(3):183-5
10833042
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
15034147
N Engl J Med. 2009 Jul 9;361(2):212-4
19564630